Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

The application of haploidentical hematopoietic stem cell transplantation (HSCT) with mesenchymal stem cell (MSC) infusion as a treatment regimen for severe aplastic anemia (SAA) has been reported to be efficacious in single-arm trials. However, it is difficult to assess without comparing the result...

Full description

Bibliographic Details
Main Authors: Zenghui Liu, Xiaoxiong Wu, Shunqing Wang, Linghui Xia, Haowen Xiao, Yonghua Li, Hongbo Li, Yuping Zhang, Duorong Xu, Danian Nie, Yongrong Lai, Bingyi Wu, Dongjun Lin, Xin Du, Zujun Jiang, Yang Gao, Xuekui Gu, Yang Xiao
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/2040620720965411

Internet

https://doi.org/10.1177/2040620720965411

Similar Items